• Brand NameDabitran
• Strength75 mg, 150 mg
• Dosage typeCapsules
• therapeutic areaCardiovascular

INDICATION

Treatment of venous thromboembolism events : (DVT) & (PE) prevention of recurrent DVT and PE. Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Prophylaxis of DVT and PE after elective hip or knee replacement surgery. Treatment of venous thromboembolic events (VTE) in pediatric patients between three months and 12 years of age.